Metraipolis › archive › dc_8eb0f0469732

Reassessing Mandatory Folic Acid Fortification for Neural Tube Defect Prevention: Evidence, Uncertainty, and Policy Implications — Europe PMC PMID:42280401

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42280401
DOI
10.3390/nu18111758
License (as archived)
solo-consultazione
Archived
2026-11-01T03:10:49.645Z
SHA-256 of the archived text
47b6fad15f34fe98a8a82f58a533a821fa28e1695c68cec225bb1d6ffe51222d
Stable URL of this page
https://metraipolis.com/documento/dc_8eb0f0469732

How to cite

Reassessing Mandatory Folic Acid Fortification for Neural Tube Defect Prevention: Evidence, Uncertainty, and Policy Implications — Europe PMC PMID:42280401 — Europe PMC (en), https://europepmc.org/article/MED/42280401 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8eb0f0469732 (Metraipolis archive dc_8eb0f0469732, sha256 47b6fad15f34fe98a8a82f58a533a821fa28e1695c68cec225bb1d6ffe51222d)
BibTeX
@misc{dc8eb0f0469732,
  title = {Reassessing Mandatory Folic Acid Fortification for Neural Tube Defect Prevention: Evidence, Uncertainty, and Policy Implications — Europe PMC PMID:42280401},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42280401},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8eb0f0469732; sha256 47b6fad15f34fe98a8a82f58a533a821fa28e1695c68cec225bb1d6ffe51222d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42280401. Agents can read the archived copy with the MCP tool read_document.